Advertisement

Polyomaviruses and Disease

  • Jaime M. Kean
  • Robert L. Garcea
Chapter

The first recognized member of the Polyomaviridae family, murine polyomavirus, was isolated in 1953 by Ludwig Gross while studying leukemia development in mice. Simian vacuolating virus (SV40) was isolated in 1960 by Sweet and Hilleman from primary monkey kidney cell cultures used to cultivate both the Salk and Sabin poliovirus vaccines (Sweet and Hilleman 1960). The human polyomaviruses, BKV and JCV, were discovered in 1971 and are ubiquitous in humans, infecting over 80% of the population by adulthood. Polyomaviruses express T-antigen proteins that circumvent cell cycle controls in order to replicate efficiently. The ability of polyomaviruses to promote cell proliferation and establish persistent infections in their hosts has implicated them in malignancy. Here we will review diseases caused by the polyomaviruses in animals and compare to those in man in order to identify general features of their pathobiology.

Animal Polyomaviruses

Polyomaviruses have been identified in many hosts...

Keywords

Merkel Cell Carcinoma Mouse Mammary Tumor Virus Hemorrhagic Cystitis SV40 Infection Umbilical Cord Blood Serum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors would like to acknowledge institutions providing financial support. Robert L. Garcea was supported by NIH/NCI grant CA37667 and Jaime M. Kean by NIH/NIAID grant T32 AI52066.

References

  1. Allander, T., K. Andreasson, et al. (2007). “Identification of a third human polyomavirus.” J Virol 81(8): 4130–6.PubMedGoogle Scholar
  2. Arthur, R. R., S. A. Grossman, et al. (1994). “Lack of association of human polyomaviruses with human brain tumors.” J Neurooncol 20(1): 55–8.PubMedGoogle Scholar
  3. Arthur, R. R. and K. V. Shah (1989). “Occurrence and significance of papovaviruses BK and JC in the urine.” Prog Med Virol 36: 42–61.PubMedGoogle Scholar
  4. Barbanti-Brodano, G., F. Martini, et al. (1998). “BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors.” Adv Virus Res 50: 69–99.PubMedGoogle Scholar
  5. Bedi, A., C. B. Miller, et al. (1995). “Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.” J Clin Oncol 13(5): 1103–9.PubMedGoogle Scholar
  6. Berger, J. R. (2003). “Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.” J Neurovirol 9(Suppl 1): 38–41.PubMedGoogle Scholar
  7. Berger, J. R., A. Chauhan, et al. (2001). “Epidemiological evidence and molecular basis of interactions between HIV and JC virus.” J Neurovirol 7(4): 329–38.PubMedGoogle Scholar
  8. Berger, J. R. and M. Concha (1995). “Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.” J Neurovirol 1(1): 5–18.PubMedGoogle Scholar
  9. Berger, J. R., R. M. Levy, et al. (1998). “Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy.” Ann Neurol 44(3): 341–9.PubMedGoogle Scholar
  10. Bergsagel, D. J., M. J. Finegold, et al. (1992). “DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.” N Engl J Med 326(15): 988–93.PubMedGoogle Scholar
  11. Binet, I., V. Nickeleit, et al. (1999). “Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss.” Transplantation 67(6): 918–22.PubMedGoogle Scholar
  12. Bocchetta, M., I. Di Resta, et al. (2000). “Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.” Proc Natl Acad Sci USA 97(18): 10214–9.PubMedGoogle Scholar
  13. Bofill-Mas, S., M. Formiga-Cruz, et al. (2001). “Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA.” J Virol 75(21): 10290–9.PubMedGoogle Scholar
  14. Bofill-Mas, S. and R. Girones (2001). “Excretion and transmission of JCV in human populations.” J Neurovirol 7(4): 345–9.PubMedGoogle Scholar
  15. Bogdanovic, G., P. Priftakis, et al. (2004). “Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation.” J Clin Microbiol 42(11): 5394–6.PubMedGoogle Scholar
  16. Brade, L., N. Muller-Lantzsch, et al. (1981). “B-lymphotropic papovavirus and possibility of infections in humans.” J Med Virol 6(4): 301–8.PubMedGoogle Scholar
  17. Brennan, D. C., I. Agha, et al. (2005). “Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.” Am J Transplant 5(3): 582–94.PubMedGoogle Scholar
  18. Brinster, R. L., H. Y. Chen, et al. (1984). “Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.” Cell 37(2): 367–79.PubMedGoogle Scholar
  19. Brown, D. W., S. D. Gardner, et al. (1984). “BK virus specific IgM responses in cord sera, young children and healthy adults detected by RIA.” Arch Virol 82(3–4): 149–60.PubMedGoogle Scholar
  20. Bryan, T. M. and R. R. Reddel (1994). “SV40-induced immortalization of human cells.” Crit Rev Oncog 5(4): 331–57.PubMedGoogle Scholar
  21. Caldarelli-Stefano, R., R. Boldorini, et al. (2000). “JC virus in human glial-derived tumors.” Hum Pathol 31(3): 394–5.PubMedGoogle Scholar
  22. Caputo, A., A. Corallini, et al. (1983). “Episomal DNA of a BK virus variant in a human insulinoma.” J Med Virol 12(1): 37–49.PubMedGoogle Scholar
  23. Carbone, M., P. Rizzo, et al. (1996). “SV40-like sequences in human bone tumors.” Oncogene 13(3): 527–35.PubMedGoogle Scholar
  24. Carter, J. J., M. M. Madeleine, et al. (2003). “Lack of serologic evidence for prevalent simian virus 40 infection in humans.” J Natl Cancer Inst 95(20): 1522–30.PubMedGoogle Scholar
  25. Chang, D., R. T. Tsai, et al. (1996). “Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan.” J Med Virol 48(2): 204–9.PubMedGoogle Scholar
  26. Chen, C. H., M. C. Wen, et al. (2001). “A regulatory region rearranged BK virus is associated with tubulointerstitial nephritis in a rejected renal allograft.” J Med Virol 64(1): 82–8.PubMedGoogle Scholar
  27. Chen, J., K. Neilson, et al. (1989). “Lymphotropic Papovavirus Early Region Is Specifically Regulated in Transgenic Mice and Efficiently Induces Neoplasia.” Journal of Virology 63(5): 2204–14.PubMedGoogle Scholar
  28. Chen, Y., J. Trofe, et al. (2006). “Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.” J Virol 80(7): 3495–505.PubMedGoogle Scholar
  29. Chesters, P. M., J. Heritage, et al. (1983). “Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.” J Infect Dis 147(4): 676–84.PubMedGoogle Scholar
  30. Chowdhury, M., M. Kundu, et al. (1993). “GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.” Oncogene 8(4): 887–92.PubMedGoogle Scholar
  31. Chowdhury, M., J. P. Taylor, et al. (1990). “Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.” Oncogene 5(12): 1737–42.PubMedGoogle Scholar
  32. Cicala, C., F. Pompetti, et al. (1993). “SV40 induces mesotheliomas in hamsters.” Am J Pathol 142(5): 1524–33.PubMedGoogle Scholar
  33. Cinque, P., S. Bossolasco, et al. (2003). “The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.” J Neurovirol 9(Suppl 1): 73–80.PubMedGoogle Scholar
  34. Cinque, P., C. Pierotti, et al. (2001). “The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.” J Neurovirol 7(4): 358–63.PubMedGoogle Scholar
  35. Clifford, D. B., C. Yiannoutsos, et al. (1999). “HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.” Neurology 52(3): 623–5.PubMedGoogle Scholar
  36. Coleman, D. V., E. F. Mackenzie, et al. (1978). “Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients.” J Clin Pathol 31(4): 338–47.PubMedGoogle Scholar
  37. Comoli, P., S. Basso, et al. (2003). “Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients.” J Am Soc Nephrol 14(12): 3197–204.PubMedGoogle Scholar
  38. Corallini, A., M. Pagnani, et al. (1987). “Association of BK virus with human brain tumors and tumors of pancreatic islets.” Int J Cancer 39(1): 60–7.PubMedGoogle Scholar
  39. Corral, I., C. Quereda, et al. (2002). “Relapsing and remitting leukoencephalopathy associated with chronic HIV infection.” Eur Neurol 48(1): 39–41.PubMedGoogle Scholar
  40. Cotterill, H. A., M. E. Macaulay, et al. (1992). “Reactivation of polyomavirus in bone marrow transplant recipients.” J Clin Pathol 45(5): 445.PubMedGoogle Scholar
  41. Dalrymple, S. A. and K. L. Beemon (1990). “BK virus T antigens induce kidney carcinomas and thymoproliferative disorders in transgenic mice.” J Virol 64(3): 1182–91.PubMedGoogle Scholar
  42. Das, D., R. B. Shah, et al. (2004). “Detection and expression of human BK virus sequences in neoplastic prostate tissues.” Oncogene 23(42): 7031–46.PubMedGoogle Scholar
  43. De Clercq, E. and A. Holy (2005). “Acyclic nucleoside phosphonates: a key class of antiviral drugs.” Nat Rev Drug Discov 4(11): 928–40.PubMedGoogle Scholar
  44. De Luca, A., M. L. Giancola, et al. (2000). “The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.” J Infect Dis 182(4): 1077–83.PubMedGoogle Scholar
  45. De Mattei, M., F. Martini, et al. (1995). “High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes.” Int J Cancer 61(6): 756–60.PubMedGoogle Scholar
  46. Del Valle, L., J. Gordon, et al. (2001). “Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system.” Cancer Res 61(10): 4287–93.PubMedGoogle Scholar
  47. Del Valle, L., J. Gordon, et al. (2002). “Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma.” J Natl Cancer Inst 94(4): 267–73.PubMedGoogle Scholar
  48. Diamandopoulos, G. T. (1972). “Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40.” Science 176(31): 173–5.PubMedGoogle Scholar
  49. Dorries, K., G. Loeber, et al. (1987). “Association of polyomaviruses JC, SV40, and BK with human brain tumors.” Virology 160(1): 268–70.PubMedGoogle Scholar
  50. Dorries, K., E. Vogel, et al. (1994). “Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals.” Virology 198(1): 59–70.PubMedGoogle Scholar
  51. Du Pasquier, R. A., K. W. Clark, et al. (2001). “JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.” J Neurovirol 7(4): 318–22.PubMedGoogle Scholar
  52. Du Pasquier, R. A., M. J. Kuroda, et al. (2003). “Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.” J Virol 77(22): 11918–26.PubMedGoogle Scholar
  53. Du Pasquier, R. A., J. E. Schmitz, et al. (2004). “Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.” J Virol 78(18): 10206–10.PubMedGoogle Scholar
  54. Eash, S., R. Tavares, et al. (2004). “Differential distribution of the JC virus receptor-type sialic acid in normal human tissues.” Am J Pathol 164(2): 419–28.PubMedGoogle Scholar
  55. Eddy, B. E., G. S. Borman, et al. (1962). “Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40.” Virology 17: 65–75.PubMedGoogle Scholar
  56. Elphick, G. F., W. Querbes, et al. (2004). “The human polyomavirus, JCV, uses serotonin receptors to infect cells.” Science 306 (5700): 1380–3.PubMedGoogle Scholar
  57. Emri, S., T. Kocagoz, et al. (2000). “Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey.” Anticancer Res 20(2A): 891–4.PubMedGoogle Scholar
  58. Enam, S., L. Del Valle, et al. (2002). “Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin.” Cancer Res 62(23): 7093–101.PubMedGoogle Scholar
  59. Erselius, J. R., B. Jostes, et al. (1990). “Cell-type-specific control elements of the lymphotropic papovavirus enhancer.” J Virol 64(4): 1657–66.PubMedGoogle Scholar
  60. Feng, H. Shuda, M. et al. (2008) “Clanal Integration of a Polyomavirus in human merkel cell carcinoma.” Science. 319 (5866):1096–100.Google Scholar
  61. Fioriti, D., M. Videtta, et al. (2005). “The human polyomavirus BK: Potential role in cancer.” J Cell Physiol 204(2): 402–6.PubMedGoogle Scholar
  62. Flaegstad, T., P. A. Andresen, et al. (1999). “A possible contributory role of BK virus infection in neuroblastoma development.” Cancer Res 59(5): 1160–3.PubMedGoogle Scholar
  63. Flaegstad, T., T. Traavik, et al. (1988). “BK virus infection in children with cancer: serological response studied by haemagglutination inhibition, neutralization, and IgG- and IgM-class specific ELISA tests.” J Med Virol 24(1): 33–44.PubMedGoogle Scholar
  64. Franks, R. R., A. Rencic, et al. (1996). “Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein.” Oncogene 12(12): 2573–8.PubMedGoogle Scholar
  65. Freund, R., A. Calderone, et al. (1991). “Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.” J Virol 65(1): 335–41.PubMedGoogle Scholar
  66. Gallia, G. L., S. A. Houff, et al. (1997). “Review: JC virus infection of lymphocytes – revisited.” J Infect Dis 176(6): 1603–9.PubMedGoogle Scholar
  67. Gamberi, G., M. S. Benassi, et al. (2000). “Presence and expression of the simian virus-40 genome in human giant cell tumors of bone.” Genes Chromosomes Cancer 28(1): 23–30.PubMedGoogle Scholar
  68. Gardner SD (1973). “Prevalence in England of antibody to human polyomavirus (BK).” Journal of British Medicine i: 77–78.Google Scholar
  69. Gardner, S. D., A. M. Field, et al. (1971). “New human papovavirus (B.K.) isolated from urine after renal transplantation.” Lancet 1(7712): 1253–7.PubMedGoogle Scholar
  70. Gardner, S. D., E. F. MacKenzie, et al. (1984). “Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.” J Clin Pathol 37(5): 578–86.PubMedGoogle Scholar
  71. Gasnault, J., P. Kousignian, et al. (2001). “Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.” J Neurovirol 7(4): 375–81.PubMedGoogle Scholar
  72. Gaynor, A., M. Nissen, M., D. et al. (2007) “Identification of a novel polyomavirus from patients with acute respiratory tract infections.” PLOS Pathog 3(5):e64.Google Scholar
  73. Geschwind, M. D., R. I. Skolasky, et al. (2001). “The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.” J Neurovirol 7(4): 353–7.PubMedGoogle Scholar
  74. Gibson, P. E., A. M. Field, et al. (1981). “Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy.” J Clin Pathol 34(6): 674–9.PubMedGoogle Scholar
  75. Gorczynska, E., D. Turkiewicz, et al. (2005). “Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation.” Biol Blood Marrow Transplant 11(10): 797–804.PubMedGoogle Scholar
  76. Goudsmit, J., P. Wertheim-van Dillen, et al. (1982). “The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils.” J Med Virol 10(2): 91–9.PubMedGoogle Scholar
  77. Graffi, A., T. Schramm, et al. (1967). “[On a new virus containing skin tumor in golden hamster].” Arch Geschwulstforsch 30(4): 277–83.PubMedGoogle Scholar
  78. Guerin, J. L., J. Gelfi, et al. (2000). “A novel polyomavirus (goose hemorrhagic polyomavirus) is the agent of hemorrhagic nephritis enteritis of geese.” J Virol 74(10): 4523–9.PubMedGoogle Scholar
  79. Haider, S., D. Nafziger, et al. (2000). “Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases.” Clin Infect Dis 31(4): E20–2.PubMedGoogle Scholar
  80. Hall, C. D., U. Dafni, et al. (1998). “Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.” N Engl J Med 338(19): 1345–51.PubMedGoogle Scholar
  81. Hernandez-Losa, J., C. G. Fedele, et al. (2005). “Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas.” Cancer 103(2): 293–8.PubMedGoogle Scholar
  82. Herrmann, M., M. Oppenlander, et al. (1995). “Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines.” J Virol 69(11): 6797–804.PubMedGoogle Scholar
  83. Hill, A. B. (1965). “The environment and disease: association or causation?” Proc R Soc Med 58: 293–300.Google Scholar
  84. Hirsch, H. H. (2005). “BK virus: opportunity makes a pathogen.” Clin Infect Dis 41(3): 354–60.PubMedGoogle Scholar
  85. Hirsch, H. H., W. Knowles, et al. (2002). “Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.” N Engl J Med 347(7): 488–96.PubMedGoogle Scholar
  86. Hirsch, H. H. and J. Steiger (2003). “Polyomavirus BK.” Lancet Infect Dis 3(10): 611–23.PubMedGoogle Scholar
  87. Hirvonen, A., K. Mattson, et al. (1999). “Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.” Mol Carcinog 26(2): 93–9.PubMedGoogle Scholar
  88. Hogan, T. F., E. C. Borden, et al. (1980). “Human polyomavirus infections with JC virus and BK virus in renal transplant patients.” Ann Intern Med 92(3): 373–8.PubMedGoogle Scholar
  89. Hogan, T. F., B. L. Padgett, et al. (1983). “Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.” Prog Clin Biol Res 105: 311–24.PubMedGoogle Scholar
  90. Horvath, C. J., M. A. Simon, et al. (1992). “Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome.” Am J Pathol 140(6): 1431–40.PubMedGoogle Scholar
  91. Houff, S. A., E. O. Major, et al. (1988). “Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.” N Engl J Med 318(5): 301–5.PubMedGoogle Scholar
  92. Houston, S., N. Roberts, et al. (2001). “Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.” Clin Infect Dis 32(1): 150–2.PubMedGoogle Scholar
  93. Howell, D. N., S. R. Smith, et al. (1999). “Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients.” Transplantation 68(9): 1279–88.PubMedGoogle Scholar
  94. Huang, H., R. Reis, et al. (1999). “Identification in human brain tumors of DNA sequences specific for SV40 large T antigen.” Brain Pathol 9(1): 33–42.PubMedGoogle Scholar
  95. Ilyinskii, P. O., M. D. Daniel, et al. (1992). “Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys.” J Virol 66(11): 6353–60.PubMedGoogle Scholar
  96. Imperiale, M. J. (2000). “The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer.” Virology 267(1): 1–7.PubMedGoogle Scholar
  97. Izzedine, H., V. Launay-Vacher, et al. (2005). “Antiviral drug-induced nephrotoxicity.” Am J Kidney Dis 45(5): 804–17.PubMedGoogle Scholar
  98. Kahan, A. V., D. V. Coleman, et al. (1980). “Activation of human polyomavirus infection-detection by cytologic technics.” Am J Clin Pathol 74(3): 326–32.PubMedGoogle Scholar
  99. Kanda, T., K. Yoshiike, et al. (1983). “Alignment of the genome of monkey B-lymphotropic papovavirus to the genomes of simian virus 40 and BK virus.” J Virol 46(1): 333–6.PubMedGoogle Scholar
  100. Kang, S. and W. R. Folk (1992). “Lymphotropic papovavirus transforms hamster cells without altering the amount or stability of p53.” Virology 191(2): 754–64.PubMedGoogle Scholar
  101. Keppler, O. T., M. Herrmann, et al. (1994). “Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation.” J Virol 68(11): 6933–9.PubMedGoogle Scholar
  102. Khalili, K., L. Del Valle, et al. (2003). “Human neurotropic polyomavirus, JCV, and its role in carcinogenesis.” Oncogene 22(33): 5181–91.PubMedGoogle Scholar
  103. Khalili, K., J. Gordon, et al. (2006). “The polyomavirus, JCV and its involvement in human disease.” Adv Exp Med Biol 577: 274–87.PubMedGoogle Scholar
  104. Kirschstein, R. L. and P. Gerber (1962). “Ependymomas produced after intracerebral inoculation of SV40 into new-born hamsters.” Nature 195: 299–300.PubMedGoogle Scholar
  105. Kitamura, T., Y. Aso, et al. (1990). “High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.” J Infect Dis 161(6): 1128–33.PubMedGoogle Scholar
  106. Klein, G., A. Powers, et al. (2002). “Association of SV40 with human tumors.” Oncogene 21(8): 1141–9.PubMedGoogle Scholar
  107. Kleinschmidt-DeMasters, B. K. and K. L. Tyler (2005). “Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.” N Engl J Med 353(4): 369–74.PubMedGoogle Scholar
  108. Knepper, J. E. and G. diMayorca (1987). “Cloning and characterization of BK virus-related DNA sequences from normal and neoplastic human tissues.” J Med Virol 21(3): 289–99.PubMedGoogle Scholar
  109. Knight, R. S., N. M. Hyman, et al. (1988). “Progressive multifocal leucoencephalopathy and viral antibody titres.” J Neurol 235(8): 458–61.PubMedGoogle Scholar
  110. Knoll, A., R. Stoehr, et al. (2003). “Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas.” Oncol Rep 10(2): 487–91.PubMedGoogle Scholar
  111. Knowles, W. A. (2006). “Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).” Adv Exp Med Biol 577: 19–45.PubMedGoogle Scholar
  112. Kondo, M., S. Kojima, et al. (1998). “Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.” Bone Marrow Transplant 22(10): 995–8.PubMedGoogle Scholar
  113. Koralnik, I. J., R. A. Du Pasquier, et al. (2002). “Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.” J Immunol 168(1): 499–504.PubMedGoogle Scholar
  114. Koralnik, I. J., R. A. Du Pasquier, et al. (2001). “JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.” J Virol 75(7): 3483–7.PubMedGoogle Scholar
  115. Krachmarov, C. P., L. G. Chepenik, et al. (1996). “Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha.” Proc Natl Acad Sci USA 93(24): 14112–7.PubMedGoogle Scholar
  116. Krautwald, M. E., H. Muller, et al. (1989). “Polyomavirus infection in budgerigars (Melopsittacus undulatus): clinical and aetiological studies.” Zentralbl Veterinarmed B 36(6): 459–67.PubMedGoogle Scholar
  117. Krynska, B., J. Otte, et al. (1999). “Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals.” Oncogene 18(1): 39–46.PubMedGoogle Scholar
  118. Laghi, L., A. E. Randolph, et al. (1999). “JC virus DNA is present in the mucosa of the human colon and in colorectal cancers.” Proc Natl Acad Sci USA 96(13): 7484–9.PubMedGoogle Scholar
  119. Langer-Gould, A., S. W. Atlas, et al. (2005). “Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.” N Engl J Med 353(4): 375–81.PubMedGoogle Scholar
  120. Lednicky, J. A., A. S. Arrington, et al. (1998). “Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.” J Virol 72(5): 3980–90.PubMedGoogle Scholar
  121. Lednicky, J. A., R. L. Garcea, et al. (1995). “Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.” Virology 212(2): 710–7.PubMedGoogle Scholar
  122. Leung, A. Y., M. T. Chan, et al. (2005). “Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.” Clin Infect Dis 40(4): 528–37.PubMedGoogle Scholar
  123. Limaye, A. P., K. R. Jerome, et al. (2001). “Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients.” J Infect Dis 183(11): 1669–72.PubMedGoogle Scholar
  124. London, W. T., S. A. Houff, et al. (1983). “Viral-induced astrocytomas in squirrel monkeys.” Prog Clin Biol Res 105: 227–37.PubMedGoogle Scholar
  125. Lukacher, A. E., Y. Ma, et al. (1995). “Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.” J Exp Med 181(5): 1683–92.PubMedGoogle Scholar
  126. Markowitz, R. B., B. A. Eaton, et al. (1991). “BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions.” J Virol 65(8): 4515–9.PubMedGoogle Scholar
  127. Markowitz, R. B., H. C. Thompson, et al. (1993). “Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.” J Infect Dis 167(1): 13–20.PubMedGoogle Scholar
  128. Marra, C. M., N. Rajicic, et al. (2002). “A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.” Aids 16(13): 1791–7.PubMedGoogle Scholar
  129. Mathur, V. S., J. L. Olson, et al. (1997). “Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature.” Am J Kidney Dis 29(5): 754–8.PubMedGoogle Scholar
  130. McCance, D. J. and C. A. Mims (1977). “Transplacental transmission of polyoma virus in mice.” Infect Immun 18(1): 196–202.PubMedGoogle Scholar
  131. Melnick, J. L. and S. Stinebaugh (1962). “Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.” Proc Soc Exp Biol Med 109: 965–8.PubMedGoogle Scholar
  132. Messing, A., H. Y. Chen, et al. (1985). “Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice.” Nature 316 (6027): 461–3.PubMedGoogle Scholar
  133. Miller, N. R., P. E. McKeever, et al. (1984). “Brain tumors of owl monkeys inoculated with JC virus contain the JC virus genome.” J Virol 49(3): 848–56.PubMedGoogle Scholar
  134. Monaco, M. C., W. J. Atwood, et al. (1996). “JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.” J Virol 70(10): 7004–12.PubMedGoogle Scholar
  135. Monaco, M. C., P. N. Jensen, et al. (1998). “Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection.” J Virol 72(12): 9918–23.PubMedGoogle Scholar
  136. Monaco, M. C., J. Shin, et al. (1998). “JC virus infection in cells from lymphoid tissue.” Dev Biol Stand 94: 115–22.PubMedGoogle Scholar
  137. Monini, P., L. de Lellis, et al. (1995). “Chimeric BK virus DNA episomes in a papillary urothelial bladder carcinoma.” Intervirology 38(5): 304–8.PubMedGoogle Scholar
  138. Moser, J. M., J. D. Altman, et al. (2001). “Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.” J Exp Med 193(5): 595–606.PubMedGoogle Scholar
  139. Moser, J. M. and A. E. Lukacher (2001). “Immunity to polyoma virus infection and tumorigenesis.” Viral Immunol 14(3): 199–216.PubMedGoogle Scholar
  140. Mosthaf, L., M. Pawlita, et al. (1985). “A viral enhancer element specifically active in human haematopoietic cells.” Nature 315(6020): 597–600.PubMedGoogle Scholar
  141. Negrini, M., P. Rimessi, et al. (1990). “Characterization of BK virus variants rescued from human tumours and tumour cell lines.” J Gen Virol 71 (Pt 11): 2731–6.PubMedGoogle Scholar
  142. Nevo, S., V. Swan, et al. (1998). “Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients.” Blood 91(4): 1469–77.PubMedGoogle Scholar
  143. Nickeleit, V., H. H. Hirsch, et al. (1999). “Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease.” J Am Soc Nephrol 10(5): 1080–9.PubMedGoogle Scholar
  144. Nickeleit, V., T. Klimkait, et al. (2000). “Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.” N Engl J Med 342(18): 1309–15.PubMedGoogle Scholar
  145. Ohsumi, S., M. Motoi, et al. (1986). “Induction of undifferentiated tumors by JC virus in the cerebrum of rats.” Acta Pathol Jpn 36(6): 815–25.PubMedGoogle Scholar
  146. Ortiz, A., P. Justo, et al. (2005). “Tubular cell apoptosis and cidofovir-induced acute renal failure.” Antivir Ther 10(1): 185–90.PubMedGoogle Scholar
  147. Padgett, B. L., D. L. Walker, et al. (1971). “Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.” Lancet 1 (7712): 1257–60.PubMedGoogle Scholar
  148. Pahari, A. and L. Rees (2003). “BK virus-associated renal problems – clinical implications.” Pediatr Nephrol 18(8): 743–8.PubMedGoogle Scholar
  149. Pawlita, M., G. Lenoir, et al. (1987). “Host range restriction of the lymphotropic papova virus (LPV) in cells of human hematopoietic origin.” Haematologica 72(Suppl 6): 71.PubMedGoogle Scholar
  150. Peinemann, F., E. M. de Villiers, et al. (2000). “Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants.” Eur J Pediatr 159(3): 182–8.PubMedGoogle Scholar
  151. Petterson, M. and W. Schaffner (1987). “A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells.” Genes Dev 1(9): 962–72.PubMedGoogle Scholar
  152. Pietropaolo, V., C. Di Taranto, et al. (1998). “Transplacental transmission of human polyomavirus BK.” J Med Virol 56(4): 372–6.PubMedGoogle Scholar
  153. Portilla, J., V. Boix, et al. (2000). “Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.” J Infect 41(2): 182–4.PubMedGoogle Scholar
  154. Portolani, M. and M. Borgatti (1978). “Stable transformation of mouse, rabbit and monkey cells and abortive transformation of human cells by BK virus, a human papovavirus.” J Gen Virol 38(2): 369–74.PubMedGoogle Scholar
  155. Power, C., P. A. Kong, et al. (1993). “Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.” Ann Neurol 34(3): 339–50.PubMedGoogle Scholar
  156. Purighalla, R., R. Shapiro, et al. (1995). “BK virus infection in a kidney allograft diagnosed by needle biopsy.” Am J Kidney Dis 26(4): 671–3.PubMedGoogle Scholar
  157. Ramos, E., C. B. Drachenberg, et al. (2002). “BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.” Clin Transpl 13: 143–53.Google Scholar
  158. Ricciardiello, L., D. K. Chang, et al. (2001). “Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues.” J Virol 75(4): 1996–2001.PubMedGoogle Scholar
  159. Ricciardiello, L., L. Laghi, et al. (2000). “JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract.” Gastroenterology 119(5): 1228–35.PubMedGoogle Scholar
  160. Roberts, M. T., A. Carmichael, et al. (2003). “Prolonged survival in AIDS-related progressive multifocal leucoencephalopathy following anti-retroviral therapy and cidofovir.” Int J Antimicrob Agents 21(4): 347–9.PubMedGoogle Scholar
  161. Royal, W., 3rd, B. Dupont, et al. (2003). “Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.” J Neurovirol 9(3): 411–9.PubMedGoogle Scholar
  162. Rziha, H. J., B. H. Belohradsky, et al. (1978). “BK virus: II. Serologic studies in children with congenital disease and patients with malignant tumors and immunodeficiencies.” Med Microbiol Immunol (Berl) 165(2): 83–92.Google Scholar
  163. Rziha, H. J., G. W. Bornkamm, et al. (1978). “BK virus: I. Seroepidemiologic studies and serologic response to viral infection.” Med Microbiol Immunol (Berl) 165(2): 73–81.Google Scholar
  164. Safak, M. and K. Khalili (2003). “An overview: Human polyomavirus JC virus and its associated disorders.” J Neurovirol 9(Suppl 1): 3–9.PubMedGoogle Scholar
  165. Salmaggi, A., E. Maccagnano, et al. (2001). “Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy.” Neurol Sci 22(1): 17–20.PubMedGoogle Scholar
  166. Scherneck, S., R. Ulrich, et al. (2001). “The hamster polyomavirus – a brief review of recent knowledge.” Virus Genes 22(1): 93–101.PubMedGoogle Scholar
  167. Schettler, C. H. (1980). “[Clinical aspect and pathology of hemorrhagic nephritis and enteritis in geese].” Tierarztl Prax 8(3): 313–20.PubMedGoogle Scholar
  168. Seber, A., X. O. Shu, et al. (1999). “Risk factors for severe hemorrhagic cystitis following BMT.” Bone Marrow Transplant 23(1): 35–40.PubMedGoogle Scholar
  169. Sehr, P., M. Muller, et al. (2002). “HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.” J Virol Methods 106(1): 61–70.PubMedGoogle Scholar
  170. Seth, P., F. Diaz, et al. (2003). “Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.” J Neurovirol 9(2): 236–46.PubMedGoogle Scholar
  171. Shah, K. and N. Nathanson (1976). “Human exposure to SV40: review and comment.” Am J Epidemiol 103(1): 1–12.PubMedGoogle Scholar
  172. Shivapurkar, N., K. Harada, et al. (2002). “Presence of simian virus 40 DNA sequences in human lymphomas.” Lancet 359(9309): 851–2.PubMedGoogle Scholar
  173. Shivapurkar, N., T. Wiethege, et al. (1999). “Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations.” J Cell Biochem 76(2): 181–8.PubMedGoogle Scholar
  174. Small, J. A., G. Khoury, et al. (1986). “Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice.” Proc Natl Acad Sci USA 83(21): 8288–92.PubMedGoogle Scholar
  175. Small, J. A., G. A. Scangos, et al. (1986). “The early region of human papovavirus JC induces dysmyelination in transgenic mice.” Cell 46(1): 13–8.PubMedGoogle Scholar
  176. Stoner, G. L., R. Alappan, et al. (2002). “BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis.” Am J Kidney Dis 39(5): 1102–12.PubMedGoogle Scholar
  177. Stratton, K., D. A. Alamario, et al. (2003). Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer, Institution of Medicine of the National Academies. Washington (DC): The National Academies Press, pp. 1–101.Google Scholar
  178. Sundsfjord, A., T. Flaegstad, et al. (1994). “BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.” J Infect Dis 169(3): 485–90.PubMedGoogle Scholar
  179. Sweet, B. H. and M. R. Hilleman (1960). “The vacuolating virus, S.V. 40.” Proc Soc Exp Biol Med 105: 420–7.PubMedGoogle Scholar
  180. Symonds, H., J. D. Chen, et al. (1991). “Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53.” J Virol 65(10): 5417–24.PubMedGoogle Scholar
  181. Tada, H., J. Rappaport, et al. (1990). “Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.” Proc Natl Acad Sci U S A 87(9): 3479–83.PubMedGoogle Scholar
  182. Taguchi, F., D. Nagaki, et al. (1975). “Transplacental transmission of BK virus in human.” Jpn J Microbiol 19(5): 395–8.PubMedGoogle Scholar
  183. Takemoto, K. K. and T. Kanda (1984). “Lymphotropic papovavirus transformation of hamster embryo cells.” J Virol 50(1): 100–5.PubMedGoogle Scholar
  184. Takemoto, K. K. and K. Segawa (1983). “A new monkey lymphotropic papovavirus: characterization of the virus and evidence of a related virus in humans.” Prog Clin Biol Res 105: 87–96.PubMedGoogle Scholar
  185. Testa, J. R. and A. Giordano (2001). “SV40 and cell cycle perturbations in malignant mesothelioma.” Semin Cancer Biol 11(1): 31–8.PubMedGoogle Scholar
  186. Velupillai, P., J. P. Carroll, et al. (2002). “Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.” J Virol 76(19): 9657–63.PubMedGoogle Scholar
  187. Velupillai, P., R. L. Garcea, et al. (2006). “Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice.” J Immunol 176(2): 1148–53.PubMedGoogle Scholar
  188. Velupillai, P., I. Yoshizawa, et al. (1999). “Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.” J Virol 73(12): 10079–85.PubMedGoogle Scholar
  189. Vilchez, R. A., C. A. Kozinetz, et al. (2003). “Simian virus 40 in human cancers.” Am J Med 114(8): 675–84.PubMedGoogle Scholar
  190. Vilchez, R. A., J. A. Lednicky, et al. (2002). “Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma.” J Acquir Immune Defic Syndr 29(2): 109–16.PubMedGoogle Scholar
  191. Viscidi, R. P. and B. Clayman (2006). “Serological cross reactivity between polyomavirus capsids.” Adv Exp Med Biol 577: 73–84.PubMedGoogle Scholar
  192. Vivaldi, A., F. Pacini, et al. (2003). “Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes.” J Clin Endocrinol Metab 88(2): 892–9.PubMedGoogle Scholar
  193. Walker, D. L. and B. L. Padgett (1983). “The epidemiology of human polyomaviruses.” Prog Clin Biol Res 105: 99–106.PubMedGoogle Scholar
  194. Walker, D. L., B. L. Padgett, et al. (1973). “Human papovavirus (JC): induction of brain tumors in hamsters.” Science 181(100): 674–6.PubMedGoogle Scholar
  195. Weber, F., C. Goldmann, et al. (2001). “Cellular and humoral immune response in progressive multifocal leukoencephalopathy.” Ann Neurol 49(5): 636–42.PubMedGoogle Scholar
  196. Weggen, S., T. A. Bayer, et al. (2000). “Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas.” Brain Pathol 10(1): 85–92.PubMedGoogle Scholar
  197. White, F. A., 3rd, M. Ishaq, et al. (1992). “JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.” J Virol 66(10): 5726–34.PubMedGoogle Scholar
  198. White, M. K. and K. Khalili (2004). “Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis.” Virology 324(1): 1–16.PubMedGoogle Scholar
  199. Yamamoto, H., T. Nakayama, et al. (2000). “High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients.” Br J Cancer 82(10): 1677–81.PubMedGoogle Scholar
  200. Yogo, Y., T. Kitamura, et al. (1990). “Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.” J Virol 64(6): 3139–43.PubMedGoogle Scholar
  201. Zdziarski, J. M., N. A. Sarich, et al. (2004). “Molecular analysis of SV-40-CAL, a new slow growing SV-40 strain from the kidney of a caged New World monkey with fatal renal disease.” Virus Genes 29(2): 183–90.PubMedGoogle Scholar
  202. Zhang, S., A. L. McNees, et al. (2005). “Quantification of vertical transmission of Murine polyoma virus by real-time quantitative PCR.” J Gen Virol 86(Pt 10): 2721–9.PubMedGoogle Scholar
  203. zur Hausen, H. and L. Gissmann (1979). “Lymphotropic papovaviruses isolated from African green monkey and human cells.” Med Microbiol Immunol (Berl) 167(3): 137–53.Google Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  1. 1.University of Colorado at Denver and Health Sciences Center,PediatricsDenverUSA

Personalised recommendations